July 9, 2026 3:55 PM
Novo Nordisk Launches Once-Weekly Basal Insulin Awiqli in India
Novo Nordisk India on Thursday announced the launch of Awiqli (insulin icodec), which the company says is the world's first once-weekly basal insulin for adults with Type 1 or Type 2 diabetes. The treatment reduces the insulin regimen from one inject...
